Article info

Download PDFPDF
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer

Authors

  1. Correspondence to Dr Robert L Coleman, The US Oncology Network, The Woodlands, TX 77380, USA; rcoleman{at}gog.org
View Full Text

Citation

Slomovitz BM, Chelariu-Raicu A, Schmeler KM, et al
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer

Publication history

  • Received July 12, 2020
  • Revision received September 10, 2020
  • Accepted September 16, 2020
  • First published October 5, 2020.
Online issue publication 
November 02, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.